方法：应用阴性和阳性症状量表（PANSS） ，韦氏康量卡片分类测验（WCST）对6 3例精神分裂症的自知力及执行功能进行了评定。
Methods:The executive function and insight were assessed in 63 patients suffering from schizophrenic on the Positive and Negative Syndrome Scale(PANSS), and Wisconsin Card Sorting Test(WCST).
于治疗前、出院1年后采用阳性和阴性症状量表(PANSS)及生活质量量表(WHOQOL - 100)进行精神症状和生活质量的评定。
All the patients were evaluated with the positive and negative symptoms scale (PANSS) and WHO Quality of Life Survey (WHOQOL 100) before treatment and 1 year after discharge.
用阳性和阴性症状量表（PANSS）评定患者的精神症状及严重程度。
Mental symptoms and the severity of the disease were evaluated with positive and negative syndrome scale(PANSS).
采用简明精神病量表(BPRS)、阳性和阴性症状量表(PANSS)进行评价。
Brief psychiatric Rating Scale (BPRS) and Positive and Negative Syndrome Scale (PANSS) were used to assess the effects.
以阳性和阴性症状量表（PANSS）评定临床疗效，以副反应量表（TESS）评定不良反应。
The efficacy was evaluated by positive and negative symptom scale(PANSS), and the side effects by treatment emergent symptom scale(TESS).
并用阳性和阴性症状量表(PANSS)评定患者的精神症状。
Psychiatric symptoms were assessed by Positive and Negative Syndrome Scale (PANSS).
采用阳性症状量表和阴性症状量表(PANSS)以评定齐拉西酮对女性精神分裂症的疗效，采用不良反应量表(TESS)评定该药物的副反应。
The positive and negative symptom scale (PANSS) is adopted to appraise the curative effect, and the treatment emergent symptom scale (TESS) is adopted to appraise by-reaction.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
Positive and negative symptom scale (PANSS) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects respectively.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
PANSS and TESS were used to assess the clinic and side effects.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
PANSS and TESS were used to assess the clinic and side effects.
应用推荐